T5423 |
PKC-theta inhibitor
|
736048-65-0
|
|
|
PKC-theta inhibitor is PKC-θinhibitor, with an IC50 of 12 nM.
|
T12496 |
PKC-theta inhibitor 1
|
1160501-81-4
|
98%
|
|
PKC-theta inhibitor 1 is an inhibitor of PKCθ (Ki of 6 nM)
|
TN1542 |
Cycloheterophyllin
|
36545-53-6
|
98%
|
|
Cycloheterophyllin has an antioxidant effect, it is a photoprotective agent that inhibits ultraviolet A (UVA)-induced oxidative stress and damage, and could be u...
|
T13637 |
DCP-LA
|
28399-31-7
|
98%
|
|
DCP-LA (FR236924), linoleic acid derivatives, selective and direct activation of PKCε.
|
T78220 |
SAMβA TFA
|
|
98%
|
|
SAMβA TFA, a selective antagonist of Mfn1-βIIPKC association conjugated to the cell permeable peptide TAT47-57, is a rationally designed inhibitor that improves ...
|
T78833 |
AJH-836
|
388621-67-8
|
98%
|
|
AJH-836 is a compound that activates Munc13-1 and PKC ε/α, demonstrating a dissociation constant (Kd) of 4.5 nM for PKCα, and facilitates the translocation of Mu...
|
T79493 |
HIV-1 protease-IN-10
|
|
98%
|
|
HIV-1 protease-IN-10 (Compound 2), exhibiting HIV-1 latency reversing activity (IC50: 0.22 μM), selectively binds to the PKCδ C1b domain (IC50: 0.69 μM) and demo...
|
T80070 |
PKCβII Peptide Inhibitor I
|
862502-26-9
|
98%
|
|
PKCβII Peptide Inhibitor I, a specific PKCβII inhibitor, exhibits cardioprotective properties in a rat cardiac ischemia/reperfusion injury model and mitigates va...
|
T80248 |
PKCε (85-92)
|
207111-98-6
|
98%
|
|
PKCε (85-92) is a biologically active peptide that functions as a specific activator of ε-PKC and induces MARCKS phosphorylation in wild-type cells, but does not...
|
T80249 |
Epsilon-V1-2, Cys-conjugated
|
|
98%
|
|
Epsilon-V1-2, a Cys-conjugated, is a biologically active peptide known as the εPKC-specific inhibitor. It hampers εPKC functionality by obstructing its transloca...
|
T80504 |
ɛPKC(85–92),Myristoylated
|
1072301-79-1
|
98%
|
|
Myristoylated ?PKC(85–92) is a myristic acid-conjugated, cell-permeable peptide activator of PKC? that has been shown to increase nitric oxide (NO) release in cu...
|
T80505 |
PKCα (C2-4) inhibitor peptide
|
|
98%
|
|
PKCα (C2-4) inhibitor peptide is a specific antagonist to PKCα that impedes the α1A-adrenoreceptor agonist A-61603 [1] from inhibiting I_Kr.
|
T80507 |
PKCθ pseudosubstrate peptide inhibitor,myristoylated
|
|
98%
|
|
Myristoylated PKCθ pseudosubstrate peptide inhibitor is a synthetic peptide utilized to investigate the mechanism of action of protein kinase C theta (PKCθ) [1]....
|
T80508 |
PKCη pseudosubstrate inhibitor,myristoylated
|
908012-19-1
|
98%
|
|
Myristoylated PKCη pseudosubstrate inhibitor is a cell-permeable compound utilized to investigate the mechanism of action of PKCη [1].
|
T80509 |
PKC 20-28,myristoylated
|
|
98%
|
|
Myristoylated protein kinase C inhibitor 20-28 (PKC 20-28,myristoylated) is a cell-permeable inhibitor of protein kinase C, utilized in cancer research [1].
|
T80511 |
PKCε inhibitor peptide,myristoylated
|
|
98%
|
|
Myristoylated PKCε inhibitor peptide (Myr-PKCε-) is a cell-permeable inhibitor consisting of a peptide linked to myristic acid that specifically inhibits protein...
|
T80514 |
TAT-SAMβA
|
|
98%
|
|
TAT-SAMβA, an RNAENFDRF (SAMβA) peptide conjugated to the TAT 47–57 protein-derived cell-penetrating peptide, acts as a selective antagonist of the Mfn1-βIIPKC a...
|
T80550 |
N-myristoyl-RKRTLRRL
|
152246-40-7
|
98%
|
|
N-myristoyl-RKRTLRRL is a compound that impedes the binding of protein kinase C (PKC) substrates and inhibits calcium (Ca2+)- and phosphatidylserine (PS)-depende...
|
T81449 |
PKC-ε translocation inhibitor peptide
|
|
98%
|
|
PKC-ε Translocation Inhibitor Peptide is a selective modulator that controls the FcγR-mediated internalization rate of opsonized beads without affecting FcαR tra...
|
T12494 |
PKC-IN-1
|
1046787-18-1
|
98%
|
|
PKC-IN-1 is an ATP-competitive and reversible conventional PKC enzymes inhibitor (PKCα, PKCβI, PKCβII, PKCθ, PKCγ, PKC mu and PKCε with IC50s of 2.3, 8.1, 7.6, 2...
|